• Je něco špatně v tomto záznamu ?

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

A. Onofri, U. Pensato, C. Rosignoli, W. Wells-Gatnik, E. Stanyer, R. Ornello, HZ. Chen, F. De Santis, A. Torrente, P. Mikulenka, G. Monte, K. Marschollek, M. Waliszewska-Prosół, W. Wiels, DM. Boucherie, D. Onan, F. Farham, L. Al-Hassany, S....

. 2023 ; 24 (1) : 8. [pub] 20230214

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu metaanalýza, systematický přehled, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004176

INTRODUCTION: Headache is the most prevalent neurological manifestation in adults and one of the leading causes of disability worldwide. In children and adolescents, headaches are arguably responsible for a remarkable impact on physical and psychological issues, yet high-quality evidence is scarce. MATERIAL AND METHODS: We searched cross-sectional and cohort studies in Embase, Medline, Web of Science, and Cochrane databases from January 1988 to June 2022 to identify the prevalence of headaches in 8-18 years old individuals. The risk of bias was examined with the Joanna Briggs Institute (JBI) scale. A random-effects model was used to estimate the pooled prevalence of pediatric headache. Subgroup analyses based on headache subtypes were also conducted. RESULTS: Out of 5,486 papers retrieved electronically, we identified 48 studies that fulfilled our inclusion criteria. The pooled prevalence of primary headaches was 11% for migraine overall [95%CI: 9-14%], 8% for migraine without aura (MwoA) [95%CI: 5-12%], 3% for migraine with aura (MwA) [95%CI:2-4%] and 17% for tension-type headache (TTH) [95% CI: 12-23%]. The pooled prevalence of overall primary headache in children and adolescents was 62% [95% CI: 53-70%], with prevalence in females and males of 38% [95% CI: 16-66%] and 27% [95% CI: 11-53%] respectively. After the removal of studies ranked as low-quality according to the JBI scale, prevalence rates were not substantially different. Epidemiological data on less common primary headaches, such as trigeminal autonomic cephalalgias, were lacking. CONCLUSION: We found an overall remarkably high prevalence of primary headaches in children and adolescents, even if flawed by a high degree of heterogeneity. Further up-to-date studies are warranted to complete the picture of pediatric headache-related burden to enhance specific public interventions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004176
003      
CZ-PrNML
005      
20230425141136.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s10194-023-01541-0 $2 doi
035    __
$a (PubMed)36782182
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Onofri, Agnese $u Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy
245    10
$a Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis / $c A. Onofri, U. Pensato, C. Rosignoli, W. Wells-Gatnik, E. Stanyer, R. Ornello, HZ. Chen, F. De Santis, A. Torrente, P. Mikulenka, G. Monte, K. Marschollek, M. Waliszewska-Prosół, W. Wiels, DM. Boucherie, D. Onan, F. Farham, L. Al-Hassany, S. Sacco, European Headache Federation School of Advanced Studies (EHF-SAS)
520    9_
$a INTRODUCTION: Headache is the most prevalent neurological manifestation in adults and one of the leading causes of disability worldwide. In children and adolescents, headaches are arguably responsible for a remarkable impact on physical and psychological issues, yet high-quality evidence is scarce. MATERIAL AND METHODS: We searched cross-sectional and cohort studies in Embase, Medline, Web of Science, and Cochrane databases from January 1988 to June 2022 to identify the prevalence of headaches in 8-18 years old individuals. The risk of bias was examined with the Joanna Briggs Institute (JBI) scale. A random-effects model was used to estimate the pooled prevalence of pediatric headache. Subgroup analyses based on headache subtypes were also conducted. RESULTS: Out of 5,486 papers retrieved electronically, we identified 48 studies that fulfilled our inclusion criteria. The pooled prevalence of primary headaches was 11% for migraine overall [95%CI: 9-14%], 8% for migraine without aura (MwoA) [95%CI: 5-12%], 3% for migraine with aura (MwA) [95%CI:2-4%] and 17% for tension-type headache (TTH) [95% CI: 12-23%]. The pooled prevalence of overall primary headache in children and adolescents was 62% [95% CI: 53-70%], with prevalence in females and males of 38% [95% CI: 16-66%] and 27% [95% CI: 11-53%] respectively. After the removal of studies ranked as low-quality according to the JBI scale, prevalence rates were not substantially different. Epidemiological data on less common primary headaches, such as trigeminal autonomic cephalalgias, were lacking. CONCLUSION: We found an overall remarkably high prevalence of primary headaches in children and adolescents, even if flawed by a high degree of heterogeneity. Further up-to-date studies are warranted to complete the picture of pediatric headache-related burden to enhance specific public interventions.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
650    _2
$a průřezové studie $7 D003430
650    _2
$a bolesti hlavy $x epidemiologie $7 D006261
650    12
$a tenzní bolesti hlavy $x epidemiologie $7 D018781
650    12
$a migréna s aurou $7 D020325
650    12
$a migréna bez aury $7 D020326
650    _2
$a prevalence $7 D015995
655    _2
$a metaanalýza $7 D017418
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Pensato, Umberto $u Neurology and Stroke Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy $u Humanitas University, Pieve Emanuele, Milan, Italy
700    1_
$a Rosignoli, Chiara $u Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy
700    1_
$a Wells-Gatnik, William $u Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy
700    1_
$a Stanyer, Emily $u Wolfson Centre for Age Related Diseases, King's College London, London, UK
700    1_
$a Ornello, Raffaele $u Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy
700    1_
$a Chen, Hui Zhou $u Wolfson Centre for Age Related Diseases, King's College London, London, UK
700    1_
$a De Santis, Federico $u Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy
700    1_
$a Torrente, Angelo $u Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy
700    1_
$a Mikulenka, Petr $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Monte, Gabriele $u Department of Neuroscience, Neurology Unit, Bambino Gesù Children's Hospital, Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Rome, Italy
700    1_
$a Marschollek, Karol $u Department of Neurology, Wroclaw Medical University, Wroclaw, Poland
700    1_
$a Waliszewska-Prosół, Marta $u Department of Neurology, Wroclaw Medical University, Wroclaw, Poland
700    1_
$a Wiels, Wietse $u Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium
700    1_
$a Boucherie, Deirdre M $u Department of Internal Medicine, Division of Vascular Medicine and Pharmacology, Erasmus MC University Medical Center, Rotterdam, the Netherlands
700    1_
$a Onan, Dilara $u Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkey
700    1_
$a Farham, Fatemeh $u Department of Headache, Iranian Center of Neurological Researchers, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Al-Hassany, Linda $u Department of Internal Medicine, Division of Vascular Medicine and Pharmacology, Erasmus MC University Medical Center, Rotterdam, the Netherlands
700    1_
$a Sacco, Simona $u Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy. simona.sacco@univaq.it
710    2_
$a European Headache Federation School of Advanced Studies (EHF-SAS)
773    0_
$w MED00005758 $t The journal of headache and pain $x 1129-2377 $g Roč. 24, č. 1 (2023), s. 8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36782182 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141133 $b ABA008
999    __
$a ok $b bmc $g 1924692 $s 1190385
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 1 $d 8 $e 20230214 $i 1129-2377 $m The Journal of headaches and pain $n J Headache Pain $x MED00005758
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace